Sino Biopharmaceutical logo

1177 - Sino Biopharmaceutical Share Price

HK$10.34 -0.3  -2.6%

Last Trade - 2:26am

Sector
Healthcare
Size
Large Cap
Market Cap £12.98bn
Enterprise Value £13.25bn
Revenue £2.64bn
Position in Universe 94th / 5945
Bullish
Bearish
Unlock 1177 Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

1177 Revenue Unlock 1177 Revenue

Net Income

1177 Net Income Unlock 1177 Revenue

Normalised EPS

1177 Normalised EPS Unlock 1177 Revenue

PE Ratio Range

1177 PE Ratio Range Unlock 1177 Revenue

Dividend Yield Range

1177 Dividend Yield Range Unlock 1177 Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2019
31st Dec 2020
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
1177 EPS Forecasts Unlock 1177 Revenue
Profile Summary

Sino Biopharmaceutical Limited is an investment holding company principally engaged in the medicine products business. The Company operates through three business segments. The Modernized Chinese Medicines and Chemical Medicines segment is engaged in the manufacture, sales and distribution of modernized Chinese medicine products and western medicine products. The Investment segment is engaged in long term investments. The Others segment is engaged in the provision of research and development activities and services to third parties, as well as related healthcare and hospital business. The Company is also involved in the property holding, the sales of health food, the manufacture and optometry of optical glasses, as well as the retail and wholesale of optical and auditory products through its subsidiaries.

Directors
Last Annual December 31st, 2018
Last Interim September 30th, 2019
Incorporated February 2, 2000
Public Since December 8, 2003
No. of Shareholders: n/a
No. of Employees: 21,514
Sector Healthcare
Industry Pharmaceuticals
Index Hang Seng Composite , Hang Seng , Hang Seng Composite LargeCap & MidCap , Hang Seng Mainland 100 , Hang Seng Composite Mid & SmallCap ,
Exchange Stock Exchange of Hong Kong Limited
Shares in Issue 12,588,304,487
Free Float (0.0%)
Eligible for
ISAs
SIPPs
1177 Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for 1177
Upcoming Events for 1177
Monday 9th December, 2019
Dividend For SBHMY.PK
Tuesday 10th December, 2019
Dividend For 1177.HK
Friday 27th March, 2020 Estimate
Q4 2019 Sino Biopharmaceutical Ltd Earnings Release
Tuesday 19th May, 2020 Estimate
Q1 2020 Sino Biopharmaceutical Ltd Earnings Release
Thursday 4th June, 2020 Estimate
Sino Biopharmaceutical Ltd Annual Shareholders Meeting
Similar to 1177
© Stockopedia 2019, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.